Intratumoral Immunotherapy for Skin Cancer: Hype or Hard Data?
Medscape's new clinician-facing analysis puts intratumoral immunotherapy under scrutiny, asking whether injecting skin tumors directly delivers real responses or just conference buzz.
Topic
Cutaneous Squamous Cell Carcinoma
Topic
Cutaneous Squamous Cell Carcinoma
CMAJ turns its attention to actinic keratosis
Canada's CMAJ has published new content on actinic keratosis, the premalignant keratinocyte dysplasia that precedes cutaneous squ…
Locally Advanced and Metastatic cSCC: Dermatologists' Role in Focus
Dermatology Times surveys the dermatologist's role in locally advanced and metastatic cSCC, from high-risk detection to multidisc…
Melanoma Vaccine 'Breakthrough': Which Cancers Come Next?
Oncology's melanoma vaccine pivot has shifted attention from proof-of-concept to pipeline. The Washington Post's headline framing…
FDA Approves Light-Based Therapy for a Common Skin Cancer
The FDA has approved a light-based treatment for a common skin cancer, adding a nonsurgical phototherapy option for non-melanoma…
Imaging mass cytometry maps cSCC immune heterogeneity in transplants
Imaging mass cytometry maps tumor microenvironment heterogeneity between metastatic and nonmetastatic cutaneous squamous cell car…
Immune Cell Dysfunction, Not Absence, Marks Skin Cancer Risk
Nonmelanoma skin cancer in immunosuppressed patients reflects immune cell dysfunction, not absence — a shift that could reshape s…
Rhenium-188 Epidermal Radionuclide Therapy in Non-Melanoma Skin Cancer
A Frontiers narrative review surveys epidermal radionuclide therapy with rhenium-188, a topical beta-emitter approach to basal an…